What is the proper place of the Ross procedure in our modern armamentarium?

被引：3

作者：

Cameron D.E. ^{[1
]}

Vricella L.A. ^{[1
]}

机构：

[1] Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD 21287

来源：

Current Cardiology Reports | 2007年 / 9卷 / 2期

关键词：

Aortic Valve; Aortic Valve Replacement; Pulmonary Valve; Bicuspid Aortic Valve; Right Ventricular Outflow Tract;

D O I：

10.1007/BF02938334

中图分类号：

学科分类号：

摘要：

Despite nearly four decades of experience, the role of pulmonary valve autotransplantation (Ross procedure) in the treatment of aortic valve disease in adults and children continues to evolve and remains controversial. As the picture of late results has unfolded, alternating waves of enthusiasm and caution have characterized its use and have led to ongoing refinements in indications and operative technique. At present, it is seen as indispensable in the treatment of aortic valve disease in infants and small children (for whom no satisfactory replacement alternative exists and for whom growth is essential), attractive for adolescents and young adults who wish to avoid anticoagulants because of childbirth and lifestyle considerations a reasonable option for selected adults who desire biologic solutions with potentially better durability than conventional bioprostheses, and contra-indicated for the elderly and those with connective tissue disorders. Young patients with bicuspid aortic valve are the most common potential recipients, but also the most controversial, because of the risk of autograft dilatation. Optimal matching of prosthesis to patient is a clinical challenge for all caretakers involved in the treatment of valvular heart disease; this review provides guidelines to identify those patients who will benefit most from the Ross procedure, and those for whom it is inadvisable. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：93 / 98

页数：5

共 37 条

[1]

Lower R.R., Stofer R.C., Shumway N.E., A study of pulmonary valve autotransplantation, Surgery, 48, pp. 1090-1100, (1960)

[2]

Ross D.N., Replacement of aortic and mitral valves with a pulmonary autograft, Lancet, 2, pp. 956-958, (1967)

[3]

Westaby S., Bosher C., Landmarks in Cardiac Surgery, (1997)

[4]

Elkins R.C., Lane M.M., McCue C., Pulmonary autograft reoperation: Incidence and management, Ann Thorac Surg, 62, pp. 450-455, (1996)

[5]

Elkins R.C., Pulmonary autograft: The optimal substitute for the aortic valve?, N Engl J Med, 330, pp. 59-60, (1994)

[6]

Gula G., Wain W.H., Ross D.N., Ten years' experience with pulmonary autograft replacements for aortic valve disease, Ann Thorac Surg, 28, pp. 392-396, (1979)

[7]

Ross D.N., Replacement of the aortic valve with a pulmonary autograft: The "switch" operation, Ann Thorac Surg, 52, pp. 1346-1350, (1991)

[8]

Matsuki O., Okita Y., Almeida R.S., Et al., Two decades' experience with aortic valve replacement with pulmonary autograft, J Thorac Cardiovasc Surg, 95, pp. 705-711, (1988)

[9]

Chambers J.C., Somerville J., Stone S., Ross D.N., Pulmonary autograft procedure for aortic valve disease, long term results of the pioneer series, Circulation, 96, pp. 2206-2214, (1997)

[10]

Al-Khaja N., Belboul A., Rashid M., Et al., The influence of age on the durability of Carpentier-Edwards biological valves, Eur J Cardiothorac Surg, 5, pp. 635-640, (1991)

← 1 2 3 4 →